FilingSEC EDGAR6-K
Evogene Reports First Half 2026 Results and Considers Reverse Share Split to Maintain Nasdaq Listing
· SEC accepted
StageOngoing
Filing content
Evogene submitted its first half 2026 results and is considering a reverse share split, approved by shareholders, to regain compliance with Nasdaq's minimum bid price requirement.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…